HSD17B10: a gene involved in cognitive function through metabolism of isoleucine and neuroactive steroids.

The HSD17B10 gene maps on chromosome Xp11.2, a region highly associated with X-linked mental retardation. This gene encodes HSD10, a mitochondrial multifunctional enzyme that plays a significant part in the metabolism of neuroactive steroids and the degradation of isoleucine. The HSD17B10 gene is composed of six exons and five introns. Its exon 5 is an alternative exon such that there are several HSD17B10 mRNA isoforms in brain. A silent mutation (c.605C-->A) and three missense mutations (c.395C-->G; c.419C-->T; c.771A-->G), respectively, cause the X-linked mental retardation, choreoathetosis, and abnormal behavior (MRXS10) and the hydroxyacyl-CoA dehydrogenase II deficiency. The latter condition seems to be a multifactorial disease due to the disturbance of more than one metabolic pathway by the HSD10 deficiency. HSD10 inactivates the positive modulators of GABAA receptors, and plays a role in the maintenance of GABAergic neuronal function. This working model may account for the mental retardation of these patients. The dehydrogenase activity is slightly inhibited by the binding of amyloid-beta peptide to the loop D of HSD10. Elevated levels of HSD10 were observed in hippocampi of Alzheimer disease patients so this multifunctional enzyme may be related to Alzheimer disease pathogenesis; however, the molecular mechanism of its involvement remains to be ascertained.

[1]  S. Yang,et al.  Role of type 10 17beta-hydroxysteroid dehydrogenase in the pathogenesis of Alzheimer's disease. , 2001, Advances in experimental medicine and biology.

[2]  J. Sass,et al.  2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency: impaired catabolism of isoleucine presenting as neurodegenerative disease , 2004, Brain and Development.

[3]  Song-Yu Yang,et al.  A Human Brain l-3-Hydroxyacyl-coenzyme A Dehydrogenase Is Identical to an Amyloid β-Peptide-binding Protein Involved in Alzheimer’s Disease* , 1998, The Journal of Biological Chemistry.

[4]  Song-Yu Yang,et al.  Type 10 17beta-hydroxysteroid dehydrogenase catalyzing the oxidation of steroid modulators of γ-aminobutyric acid type A receptors , 2005, Molecular and Cellular Endocrinology.

[5]  D. Koshland.  Crazy, but correct , 2004, Nature.

[6]  J. Adamski,et al.  Multifunctionality of human 17β-hydroxysteroid dehydrogenases , 2006, Molecular and Cellular Endocrinology.

[7]  V. McKusick.  Mendelian Inheritance in Man and Its Online Version, OMIM , 2007, The American Journal of Human Genetics.

[8]  Song-Yu Yang,et al.  Multiple functions of type 10 17β-hydroxysteroid dehydrogenase , 2005, Trends in Endocrinology & Metabolism.

[9]  R. Wanders,et al.  2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency in a 23-year-old man , 2002, Journal of Inherited Metabolic Disease.

[10]  H. Willard,et al.  X-inactivation profile reveals extensive variability in X-linked gene expression in females , 2005, Nature.

[11]  Song-Yu Yang,et al.  Characterization and localization of human type10 17β-hydroxysteroid dehydrogenase , 2001 .

[12]  B. McEwen.  Invited review: Estrogens effects on the brain: multiple sites and molecular mechanisms. , 2001, Journal of applied physiology.

[13]  G. Leipnitz,et al.  Inhibition of energy metabolism by 2-methylacetoacetate and 2-methyl-3-hydroxybutyrate in cerebral cortex of developing rats , 2005, Journal of Inherited Metabolic Disease.

[14]  He Xy,et al.  Roles of type 10 17beta-hydroxysteroid dehydrogenase in intracrinology and metabolism of isoleucine and fatty acids. , 2006 .

[15]  Song-Yu Yang,et al.  3‐Hydroxyacyl‐CoA dehydrogenase and short chain 3‐hydroxyacyl‐CoA dehydrogenase in human health and disease , 2005, The FEBS journal.

[16]  H. Schulz,et al.  Short-chain 3-hydroxy-2-methylacyl-CoA dehydrogenase from rat liver: purification and characterization of a novel enzyme of isoleucine metabolism. , 1995, Archives of biochemistry and biophysics.

[17]  L. Tjernberg,et al.  Binding of amyloid β‐peptide to mitochondrial hydroxyacyl‐CoA dehydrogenase (ERAB): regulation of an SDR enzyme activity with implications for apoptosis in Alzheimer's disease , 1999 .

[18]  Xi Chen,et al.  Materials and Methods Som Text Figs. S1 and S2 Table S1 References Abad Directly Links A␤ to Mitochondrial Toxicity in Alzheimer's Disease , 2022 .

[19]  Ronald J A Wanders,et al.  Clinical variability in 3‐hydroxy‐2‐methylbutyryl‐coa dehydrogenase deficiency , 2002, Annals of neurology.

[20]  Ying Xu,et al.  Structural genomics analysis of alternative splicing and application to isoform structure modeling. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[21]  W. Kaczmarski,et al.  Presence of hydroxysteroid dehydrogenase type 10 in amyloid plaques (APs) of Hsiao’s APP-Sw transgenic mouse brains, but absence in APs of Alzheimer’s disease brains , 2002, Brain Research.

[22]  P. Greengard,et al.  Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides , 1998, Nature Medicine.

[23]  J. Gécz,et al.  Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation. , 2005, American journal of human genetics.

[24]  C. Schwartz,et al.  Mutations in PHF8 are associated with X linked mental retardation and cleft lip/cleft palate , 2005, Journal of Medical Genetics.

[25]  M. Frosch,et al.  Amyloid beta -peptide-binding alcohol dehydrogenase is a component of the cellular response to nutritional stress. , 2000, The Journal of biological chemistry.

[26]  Song-Yu Yang,et al.  Intrinsic alcohol dehydrogenase and hydroxysteroid dehydrogenase activities of human mitochondrial short-chain L-3-hydroxyacyl-CoA dehydrogenase. , 2000, The Biochemical journal.

[27]  T. Hashimoto,et al.  Two mitochondrial 3-hydroxyacyl-CoA dehydrogenases in bovine liver. , 1996, Journal of biochemistry.

[28]  Xi Chen,et al.  An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease , 1997, Nature.

[29]  R. Kooy,et al.  A new neurological syndrome with mental retardation, choreoathetosis, and abnormal behavior maps to chromosome Xp11. , 1999, American journal of human genetics.

[30]  Pedro A Fernandes,et al.  Comparative evolutionary genomics of the HADH2 gene encoding Aβ-binding alcohol dehydrogenase/17β-hydroxysteroid dehydrogenase type 10 (ABAD/HSD10) , 2006, BMC Genomics.

[31]  R. Wanders,et al.  Spastic diplegia and periventricular white matter abnormalities in 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, a defect of isoleucine metabolism: differential diagnosis with hypoxic-ischemic brain diseases. , 2004, Molecular genetics and metabolism.

[32]  D. Lin,et al.  Abundant type 10 17 beta-hydroxysteroid dehydrogenase in the hippocampus of mouse Alzheimer's disease model. , 2002, Brain research. Molecular brain research.

[33]  R. Wanders,et al.  2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency is caused by mutations in the HADH2 gene. , 2003, American journal of human genetics.

[34]  C. Pérez-Cerdá,et al.  Neuroimage findings in 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency. , 2007, Pediatric neurology.

[35]  Steven G. Clarke,et al.  Role of ERAB/l-3-Hydroxyacyl-coenzyme A Dehydrogenase Type II Activity in Aβ-induced Cytotoxicity* , 1999, The Journal of Biological Chemistry.

[36]  R. Stevenson.  Advances in X-linked mental retardation , 2005, Current opinion in pediatrics.

[37]  A. Krainer,et al.  Listening to silence and understanding nonsense: exonic mutations that affect splicing , 2002, Nature Reviews Genetics.

[38]  J. Wegiel,et al.  Intracellular oxidation of allopregnanolone by human brain type 10 17beta-hydroxysteroid dehydrogenase , 2005, Brain Research.

[39]  L. Hurst,et al.  Hearing silence: non-neutral evolution at synonymous sites in mammals , 2006, Nature Reviews Genetics.

[40]  P. Rejto,et al.  Crystal structure of human ABAD/HSD10 with a bound inhibitor: implications for design of Alzheimer's disease therapeutics. , 2004, Journal of molecular biology.

[41]  Xue‐Ying He,et al.  3-hydroxyacyl-CoA dehydrogenase (HAD) deficiency replaces short-chain hydroxyacyl-CoA dehydrogenase (SCHAD) deficiency as well as medium- and short-chain hydroxyacyl-CoA dehydrogenase (M/SCHAD) deficiency as the consensus name of this fatty acid oxidation disorder. , 2007, Molecular genetics and metabolism.

[42]  V. Sorrentino,et al.  Unusually severe expression of craniofacial features in Aarskog‐Scott syndrome due to a novel truncating mutation of the FGD1 gene , 2007, American journal of medical genetics. Part A.

[43]  S. Grant,et al.  The role of neuronal complexes in human X-linked brain diseases. , 2007, American journal of human genetics.

[44]  C. Schwartz,et al.  The reduced expression of the HADH2 protein causes X-linked mental retardation, choreoathetosis, and abnormal behavior. , 2007, American journal of human genetics.

[45]  H. Ropers,et al.  X-linked mental retardation , 2005, Nature Reviews Genetics.

[46]  Song-Yu Yang,et al.  Oxidative 3α-hydroxysteroid dehydrogenase activity of human type 10 17β-hydroxysteroid dehydrogenase , 2003, The Journal of Steroid Biochemistry and Molecular Biology.

[47]  R. Wanders,et al.  Progressive Infantile Neurodegeneration Caused by 2-Methyl-3-Hydroxybutyryl-CoA Dehydrogenase Deficiency: A Novel Inborn Error of Branched-Chain Fatty Acid and Isoleucine Metabolism , 2000, Pediatric Research.

[48]  Alastair M. Hosie,et al.  Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites , 2006, Nature.

[49]  J. Thyberg,et al.  Expanded substrate screenings of human and Drosophila type 10 17beta-hydroxysteroid dehydrogenases (HSDs) reveal multiple specificities in bile acid and steroid hormone metabolism: characterization of multifunctional 3alpha/7alpha/7beta/17beta/20beta/21-HSD. , 2003, The Biochemical journal.

[50]  Ronald J A Wanders,et al.  2-Methyl-3-Hydroxybutyryl-CoA Dehydrogenase (MHBD) Deficiency: An X-linked Inborn Error of Isoleucine Metabolism that May Mimic a Mitochondrial Disease , 2005, Pediatric Research.

[51]  J. Trauger,et al.  Kinetics of allopregnanolone formation catalyzed by human 3 alpha-hydroxysteroid dehydrogenase type III (AKR1C2). , 2002, Biochemistry.

[52]  H. Schulz,et al.  Mitochondrial β-Oxidation of 2-Methyl Fatty Acids in Rat Liver , 1995 .

[53]  A. Musio,et al.  X-linked Cornelia de Lange syndrome owing to SMC1L1 mutations , 2006, Nature Genetics.

[54]  Toshimichi Ikemura,et al.  Condon usage tabulated from the international DNA sequence databases , 1996, Nucleic Acids Res..

[55]  R. Wanders,et al.  3-Hydroxy-2-methylbutyryl-CoA dehydrogenase deficiency , 2003, Journal of Inherited Metabolic Disease.

[56]  Song-Yu Yang,et al.  Human Brain Short Chain l-3-Hydroxyacyl Coenzyme A Dehydrogenase Is a Single-domain Multifunctional Enzyme , 1999, The Journal of Biological Chemistry.

[57]  HSD17B10 replaces HADH2 as the approved designation for the gene mutated in 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency. , 2007, Molecular genetics and metabolism.

[58]  S. Korman.  Inborn errors of isoleucine degradation: a review. , 2006, Molecular genetics and metabolism.

[59]  M Krook,et al.  Short-chain dehydrogenases/reductases (SDR). , 1995, Biochemistry.